Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial Cancer

Metabolic reprogramming is increasingly recognised as one of the defining hallmarks of tumorigenesis. There is compelling evidence to suggest that endometrial cancer develops and progresses in the context of profound metabolic dysfunction. Whilst the incidence of endometrial cancer continues to rise...

Descripción completa

Detalles Bibliográficos
Autores principales: Njoku, Kelechi, Sutton, Caroline J.J, Whetton, Anthony D., Crosbie, Emma J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463916/
https://www.ncbi.nlm.nih.gov/pubmed/32751940
http://dx.doi.org/10.3390/metabo10080314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463916/
https://www.ncbi.nlm.nih.gov/pubmed/32751940
http://dx.doi.org/10.3390/metabo10080314

Ejemplares similares